United Kingdom Pharmaceuticals

GSK plc (GSK)

Track

Over the past 90 days, GSK plc insiders have exclusively engaged in buying activity, totaling approximately $1.08 million in purchases across 72 transactions. No insider sales were recorded. This buying trend involves 25 insiders, including key executives, despite a 9.1% decline in stock price over the same period and a slight miss in the last earnings report.
Ticker: GSK Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for GSK plc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Victoria Whyte
SVP & Company Secretary
1 purchase — total 100,000 GBP
Buy 13 Jul 2026
Value £1,011,344.14 | Price 210.90 | Shares 23,909
Buy 13 Jul 2026
Value £4,682,142.61 | Price 494.73 | Shares 14,150
Buy 13 Jul 2026
Value £895,363.51 | Price 102.12 | Shares 9,522
Buy 13 Jul 2026
Value £100,000.00 | Price 19.76 | Shares 1,000
Through Neil Falkingham, a closely affiliated person
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Through Philip Thomson, a closely affiliated person
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Through Neil Falkingham, a closely affiliated person
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Through Neil Falkingham, a closely affiliated person
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Through Victoria Whyte, a closely affiliated person
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Buy 9 Jul 2026
Value £100,000.00 | Price 19.63 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-14 2026-07-13 B Purchase
3.2
Victoria Whyte

SVP & Company Secretary

Officer
23,909
210.90
£1,011,344 		23,909 210.90 £1,011,344
2026-07-14 2026-07-13 B Purchase
3.2
David Redfern

President Corporate Development
14,150
494.73
£4,682,143 		14,150 494.73 £4,682,143
2026-07-14 2026-07-13 B Purchase
2.3
Lynn Baxter

President, Europe

Through Neil Falkingham, a closely affiliated person
36,953
98.39
£157,728 		36,953 98.39 £157,728
2026-07-14 2026-07-13 B Purchase
3.2
David Redfern

President Corporate Development
1,000
19.76
£100,000 		1,000 19.76 £100,000
2026-07-14 2026-07-09 B Purchase
3.3
Kate Thomson

President, Global Affairs

Through Philip Thomson, a closely affiliated person
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
2.3
Lynn Baxter

President, Europe

Through Neil Falkingham, a closely affiliated person
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
3.1
Tony Wood

Chief Scientific Officer

Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
3.0
Deborah Waterhouse

CEO, ViiV Healthcare and President, Global Health, GSK

Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
2.9
Philip Thomson

President, Global Affairs
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
3.2
Regis Simard

President, Global Supply Chain
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
3.2
David Redfern

President Corporate Development
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
2.4
Roanne Parry

Chief People Officer

Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
1.3
Nina Mojas

President, Global Product Strategy
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
2.8
James Ford

SVP and Group General Counsel, Legal and Compliance

Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
3.3
Mike Crichton

President, International
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-14 2026-07-09 B Purchase
3.0
Luke Miels

Chief Executive Officer

Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-13 2026-07-09 B Purchase
3.2
Iain Whyte

SVP & Company Secretary

Through Victoria Whyte, a closely affiliated person Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-13 2026-07-09 B Purchase
3.2
Victoria Whyte

SVP & Company Secretary

Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-13 2026-07-09 B Purchase
2.3
Lynn Baxter

President, Europe

Through Neil Falkingham, a closely affiliated person
1,000
19.63
£100,000 		1,000 19.63 £100,000
2026-07-13 2026-07-09 B Purchase
3.2
Victoria Whyte

SVP & Company Secretary

Officer
1,000
19.63
£100,000 		1,000 19.63 £100,000
Explore more

More insider trading research around GSK plc

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe
Insider trades in Europe Stoxx 600